Ron Cohen
2011
In 2011, Ron Cohen earned a total compensation of $3.8M as President and Chief Executive Officer at Acorda Therapeutics, a 61% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $557,920 |
|---|---|
| Option Awards | $1,605,196 |
| Salary | $635,000 |
| Stock Awards | $965,125 |
| Other | $7,350 |
| Total | $3,770,591 |
Cohen received $1.6M in option awards, accounting for 43% of the total pay in 2011.
Cohen also received $557.9K in non-equity incentive plan, $635K in salary, $965.1K in stock awards and $7.4K in other compensation.
Rankings
In 2011, Ron Cohen's compensation ranked 1,578th out of 10,747 executives tracked by ExecPay. In other words, Cohen earned more than 85.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,578 out of 10,747 | 85th |
Division Manufacturing | 574 out of 3,960 | 86th |
Major group Chemicals And Allied Products | 125 out of 1,033 | 88th |
Industry group Drugs | 71 out of 781 | 91st |
Industry Biological Products, Except Diagnostic Substances | 9 out of 157 | 94th |
Source: SEC filing on April 25, 2014.
Cohen's colleagues
We found five more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2011.
2011
Jane Wasman
Acorda Therapeutics
General Counsel
2011
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2011
Thomas Wessel
Acorda Therapeutics
Chief Medical Officer
2011
David Lawrence
Acorda Therapeutics
Chief Financial Officer
2011
Lauren Sabella
Acorda Therapeutics
Executive Vice President, Commercial Development
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019